Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Philips Hains Insider Profile
4 Followers
Philips Hains, Director at Chimeric Therapeutics Ltd., holds 10.33M shares in Chimeric Therapeutics Ltd. (Ticker: AU:CHM). Most recently, Philips Hains Bought AU$3,571,429 shares of Chimeric Therapeutics Ltd. on Dec 14, 2023 for an estimated value of 100.00K.
Philips Hains has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Philips Hains holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Philips Hains
Philips Hains's Trading History
List of latest transactions for each holding click on a transaction to see Philips Hains's performance on stock
You May Also Like
Philips Hains insider profile FAQ
What is the percentage of profitable transactions made by Philips Hains?
The percentage of profitable transactions made by Philips Hains is ―.
What is the average return per transaction made by Philips Hains?
The average return per transaction made by Philips Hains is ―.
What stocks does Philips Hains hold?
Philips Hains holds: AU:CHM stocks.
What was Philips Hains’s latest transaction?
Philips Hains latest transaction was an Informative Buy of AU$100.00K.
What was Philips Hains's most profitable transaction?
Philips Hains’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Philips Hains's role in Chimeric Therapeutics Ltd.?
Philips Hains's role in Chimeric Therapeutics Ltd. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.